This country profile provides an overview of Namibia’s progress in reaching those in need of mass NTD treatment based on 2019 data.
*This includes all countries in Africa that are endemic for at least one of the five NTDs
Treatment coverage
Elephantiasis
N/A
Blinding trachoma
0%
Intestinal worms
0%
Bilharzia
0%
River blindness
N/A
Zero
people received treatment in Namibia in 2019
1.09 million
people did not receive treatment in Namibia in 2019
Elephantiasis
Namibia does not require mass treatment for elephantiasis.
Blinding trachoma
Namibia may require interventions for blinding trachoma, investigation needed.
Intestinal worms
Treatment coverage was not reported in 2018 and 0% in 2019.
Pre-sch and school-aged children needing treatment
811k
Pre-sch and school-aged children needing treatment
Not reported
Bilharzia
Treatment coverage was not reported in 2018 and 0% in 2019.
School-aged children needing treatment
204k
School-aged children needing treatment
Not reported
River blindness
Namibia does not require mass treatment for river blindness.
The 
ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Namibia.